10X Genomics, Inc. is a pharmaceutical company based in the United States, specializing in life science technology. They offer a range of solutions for analyzing biological systems, including instruments, consumables, and software. With a focus on ESG factors, 10X Genomics has a medium-risk rating with an ESG score of 22.5. Their product portfolio includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software. The company generates most of its revenue from consumables.